{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:56:46Z","timestamp":1762610206592,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Variants in COL4A3 and COL4A4 cause autosomal dominant and recessive Alport syndrome, yet data on their distribution and clinical expression in different populations remain limited. This study investigated genotype\u2013phenotype correlations and the distribution of COL4A3\/COL4A4 variants in a Lithuanian Alport syndrome cohort. A total of 221 individuals from Lithuania were analyzed for COL4A3 and COL4A4 variants using either next-generation sequencing or Sanger sequencing in order to assess variant distribution and associated clinical features. Only individuals with pathogenic, likely pathogenic, or uncertain significance variants were included. Fifty-two individuals (38 index cases) with pathogenic, likely pathogenic, or variants of uncertain significance were identified, as follows: forty-eight were heterozygous, four had autosomal recessive, and four had digenic Alport syndrome. COL4A3 variants were found in 9.5% (21\/221) and COL4A4 in 17.6% (39\/221). Among the 28 identified variants, 18 were novel. Glycine substitutions (n = 8) were the most frequent and associated with worse kidney outcomes and increased hearing abnormalities. Hematuria was diagnosed significantly earlier than proteinuria (p = 0.05). Most individuals with autosomal dominant Alport syndrome had normal kidney function (eGFR &gt; 90 mL\/min\/1.73 m2), while those with autosomal recessive Alport syndrome had more severe disease. Kidney failure occurred in 2\/4 (50%) autosomal recessive Alport syndrome and 2\/48 (4%) autosomal dominant Alport syndrome cases. A significant inverse correlation was found between eGFR and age in proteinuric individuals (r = \u20130.737; p = 0.013). This study expands knowledge of Alport syndrome in the Lithuanian population and contributes novel variant data to the global Alport syndrome genetic database.<\/jats:p>","DOI":"10.3390\/ijms26157639","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T10:58:26Z","timestamp":1754564306000},"page":"7639","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lithuanian Study on COL4A3 and COL4A4 Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families"],"prefix":"10.3390","volume":"26","author":[{"given":"Agne","family":"Cerkauskaite-Kerpauskiene","sequence":"first","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3738-1319","authenticated-orcid":false,"given":"Milda","family":"Navickaite","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Savige","sequence":"additional","affiliation":[{"name":"The University of Melbourne, Department of Medicine (MH and NH), Royal Melbourne Hospital Level CSB, Parkville, VIC 3050, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0117-6476","authenticated-orcid":false,"given":"Gabija","family":"Mazur","sequence":"additional","affiliation":[{"name":"Centre for Medical Genetics, Vilnius University Hospital Santaros Klinikos, LT-08406 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2044-6346","authenticated-orcid":false,"given":"Deimante","family":"Brazdziunaite","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolis","family":"Azukaitis","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerda","family":"Slazaite","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-1730","authenticated-orcid":false,"given":"Arvydas","family":"Laurinavicius","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-468X","authenticated-orcid":false,"given":"Marius","family":"Miglinas","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-924X","authenticated-orcid":false,"given":"Vija","family":"Vainutiene","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Strupaite-Sileikiene","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ausrine","family":"Misevice","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaiva","family":"Mickeviciene","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-5044","authenticated-orcid":false,"given":"Rimante","family":"Cerkauskiene","sequence":"additional","affiliation":[{"name":"Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ki.1996.459","article-title":"Alport Syndrome","volume":"50","author":"Kashtan","year":"1996","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gretz, N., Broyer, M., Brunner, F.P., Brynger, H., Donckerwolcke, R.A., Jacobs, C., Kramer, P., Selwood, N.H., and Wing, A.J. (1987). Alport\u2019s syndrome as a cause of renal failure in Europe. Pediatr. Nephrol., 411\u2013415.","DOI":"10.1007\/BF00849245"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0272-6386(89)80165-9","article-title":"Twenty-Three Years of Dialysis and Transplantation in Europe: Experiences of the EDTA Registry","volume":"14","author":"Wing","year":"1989","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005792-199909000-00005","article-title":"Alport Syndrome. An Inherited Disorder of Renal, Ocular, and Cochlear Basement Membranes","volume":"78","author":"Kashtan","year":"1999","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rheault, M.N., and Kashtan, C.E. (2015). Inherited Glomerular Diseases. Pediatric Nephrology, Springer. [7th ed.].","DOI":"10.1007\/978-3-662-43596-0_79"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrneph.2013.109","article-title":"The Glomerular Basement Membrane as a Barrier to Albumin","volume":"9","author":"Suh","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport Syndrome: A Unified Classification of Genetic Disorders of Collagen IV A345: A Position Paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cge.12258","article-title":"Unbiased next Generation Sequencing Analysis Confirms the Existence of Autosomal Dominant Alport Syndrome in a Relevant Fraction of Cases","volume":"86","author":"Fallerini","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_10","first-page":"S20","article-title":"Alport\u2019s Syndrome: Experience at H\u00f4pital Necker","volume":"11","author":"Habib","year":"1982","journal-title":"Kidney Int. Suppl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","article-title":"Alport\u2019s Syndrome. A Report of 58 Cases and a Review of the Literature","volume":"70","author":"Gubler","year":"1981","journal-title":"Am. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","article-title":"Diagnosis, management and treatment of the Alport syndrome\u20142024 guideline on behalf of ERKNet, ERA and ESPN","volume":"40","author":"Torra","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 Mutations and Features in Individuals with Autosomal Recessive Alport Syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A \u201cEuropean Community Alport Syndrome Concerted Action\u201d Study","volume":"14","author":"Jais","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-Linked Alport Syndrome: Natural History in 195 Families and Genotype- Phenotype Correlations in Males","volume":"11","author":"Jais","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","first-page":"1218","article-title":"Meta-Analysis of Genotype-Phenotype Correlation in X-Linked Alport Syndrome: Impact on Clinical Counselling","volume":"17","author":"Gross","year":"2002","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_18","first-page":"11","article-title":"Alport\u2019s Syndrome in Adult Age","volume":"118","author":"Putarek","year":"1996","journal-title":"Lije\u00e8 Vjesn"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.10581014","article-title":"Ocular Features in Alport Syndrome: Pathogenesis and Clinical Significance","volume":"10","author":"Savige","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cerkauskaite, A., Savige, J., Janonyte, K., Jeremiciute, I., Miglinas, M., Kazenaite, E., Laurinavicius, A., Strupaite-Sileikiene, R., Vainutiene, V., and Burnyte, B. (2022). Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families with Alport Syndrome. Front. Med., 9.","DOI":"10.3389\/fmed.2022.859521"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Savige, J., Huang, M., Croos Dabrera, M.S., Shukla, K., and Gibson, J. (2022). Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome. Front. Med., 9.","DOI":"10.3389\/fmed.2022.865034"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00467-015-3302-4","article-title":"Identification of 47 Novel Mutations in Patients with Alport Syndrome and Thin Basement Membrane Nephropathy","volume":"31","author":"Weber","year":"2016","journal-title":"Pediatr. Nephrol. Berl. Ger."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.kint.2020.10.040","article-title":"Mild X-Linked Alport Syndrome Due to the COL4A5 G624D Variant Originating in the Middle Ages Is Predominant in Central\/East Europe and Causes Kidney Failure in Midlife","volume":"99","author":"Bielska","year":"2021","journal-title":"Kidney Int."},{"key":"ref_24","first-page":"3554","article-title":"Aortic Abnormalities in Males with Alport Syndrome","volume":"25","author":"Kashtan","year":"2010","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12688\/f1000research.9636.1","article-title":"Alport Syndrome: Facts and Opinions","volume":"6","author":"Kashtan","year":"2017","journal-title":"F1000Research"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of Renal Failure and Nephroprotection by RAAS Inhibition in Heterozygous Carriers of X-Chromosomal and Autosomal Recessive Alport Mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic Utility of Exome Sequencing for Kidney Disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_29","first-page":"2721","article-title":"Clinico-Pathological Correlations in 127 Patients in 11 Large Pedigrees, Segregating One of Three Heterozygous Mutations in the COL4A3\/COL4A4 Genes Associated with Familial Haematuria and Significant Late Progression to Proteinuria and Chronic Kidney Disease from Focal Segmental Glomerulosclerosis","volume":"24","author":"Pierides","year":"2009","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1681\/ASN.2007040444","article-title":"COL4A3\/COL4A4 Mutations Producing Focal Segmental Glomerulosclerosis and Renal Failure in Thin Basement Membrane Nephropathy","volume":"18","author":"Voskarides","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_31","first-page":"1272","article-title":"New Therapeutic Options for Alport Syndrome","volume":"34","author":"Torra","year":"2019","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","article-title":"A Review of Clinical Characteristics and Genetic Backgrounds in Alport Syndrome","volume":"23","author":"Nozu","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study","volume":"78","author":"Furlano","year":"2021","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","article-title":"Prevalence of Clinical, Pathological and Molecular Features of Glomerular Basement Membrane Nephropathy Caused by COL4A3 or COL4A4 Mutations: A Systematic Review","volume":"13","author":"Matthaiou","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1007\/s00467-021-05040-9","article-title":"Genotype-Phenotype Correlations and Nephroprotective Effects of RAAS Inhibition in Patients with Autosomal Recessive Alport Syndrome","volume":"36","author":"Zhang","year":"2021","journal-title":"Pediatr. Nephrol. Berl. Ger."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","article-title":"Natural History of Genetically Proven Autosomal Recessive Alport Syndrome","volume":"29","author":"Oka","year":"2014","journal-title":"Pediatr. Nephrol. Berl. Ger."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","article-title":"Thin Basement Membrane Nephropathy","volume":"64","author":"Savige","year":"2003","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0994-77","article-title":"Identification of Mutations in the Alpha 3(IV) and Alpha 4(IV) Collagen Genes in Autosomal Recessive Alport Syndrome","volume":"8","author":"Mochizuki","year":"1994","journal-title":"Nat. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7639\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:25:24Z","timestamp":1760034324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":38,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157639"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157639","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}